首页> 外国专利> BLOOD BIOMARKER CONTAINING DIPEPTIDYL PEPTIDASE-4 FOR DIAGNOSIS OF OSTEOPOROTIC FRACTURE RISK

BLOOD BIOMARKER CONTAINING DIPEPTIDYL PEPTIDASE-4 FOR DIAGNOSIS OF OSTEOPOROTIC FRACTURE RISK

机译:含二肽肽酶-4的血液生物标志物诊断骨质疏松性骨折风险

摘要

The present invention relates to a blood biomarker for predicting or diagnosing the osteoporotic fracture risk from concentrations of dipeptidyl peptidase-4. The blood biomarker containing dipeptidyl peptidase-4 for diagnosing the osteoporotic fracture risk can predict or diagnose the osteoporotic fracture risk from concentrations of dipeptidyl peptidase-4 existing in plasma, and has significantly improved effects of predicting or diagnosing the osteoporotic fracture risk compared to an existing biomarker.;COPYRIGHT KIPO 2017
机译:本发明涉及用于根据二肽基肽酶-4的浓度来预测或诊断骨质疏松性骨折风险的血液生物标志物。用于诊断骨质疏松性骨折风险的包含二肽基肽酶-4的血液生物标记物可以根据血浆中存在的二肽基肽酶-4的浓度预测或诊断骨质疏松性骨折的风险,与现有的骨质疏松性骨折风险相比,具有显着改善的预测或诊断性骨质疏松性骨折风险的效果生物标志物。; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号